Parasite | Eso | Sto | Cancer | ESD
[KDDW 2019] - End of document
2019³â 11¿ù 28ÀϺÎÅÍ 30ÀϱîÁö ¿¸®´Â KDDW2019¿¡¼ ¸¹Àº »óºÎÀ§Àå°ü ÇÁ·Î±×·¥µéÀÌ ÁøÇàµÇ¾ú½À´Ï´Ù.
11¿ù 29ÀÏ
¿ì¸®³ª¶ó¿¡¼ Ç×»ýÁ¦ ³»¼º¿¡ µû¸¥ 4Â÷ Ä¡·á¿Í µ¿½Ã Ä¡·á ¼ºÀûÀÔ´Ï´Ù.
ÀϺ» third-line treatment ¼ºÀû ¿ä¾àÀÔ´Ï´Ù.
ÀϺ»ÀÇ P-CABÀÎ vonoprazanÀ» È°¿ëÇÑ Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á ¼ºÀû¿¡ ´ëÇÑ °á·ÐÀÔ´Ï´Ù. Clarithromycin resistance¸¦ »ó´çºÎºÐ ±Øº¹ÇÒ ¼ö ÀÖ´Ù´Â ÁÖÀåÀ̾ú½À´Ï´Ù.
[2019-11-30]
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (since 1999-8-23)